Lockheed Martin Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-5,210
Closed -$878K 121
2019
Q1
$878K Hold
5,210
0.04% 102
2018
Q4
$507K Hold
5,210
0.02% 78
2018
Q3
$900K Hold
5,210
0.04% 57
2018
Q2
$727K Hold
5,210
0.03% 68
2018
Q1
$587K Hold
5,210
0.02% 108
2017
Q4
$688K Sell
5,210
-90
-2% -$10.6K 0.03% 108
2017
Q3
$538K Buy
+5,300
New +$568K 0.03% 125
2017
Q2
Sell
-9,800
Closed -$1.19M 147
2017
Q1
$1.19M Buy
+9,800
New +$1.2M 0.07% 112

Other funds holding GWPH

Lockheed Martin Investment Management's GWPH Position: Q2 2019 in Review

Lockheed Martin Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 5,210 shares — an estimated $878K sold.

Lockheed Martin Investment Management first reported a position in GWPH in Q1 2017 and held it in 8 quarters. The position peaked at $1.19M in Q1 2017. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

  • Lockheed Martin Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 5,210 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $878K.
  • Lockheed Martin Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 8 quarters.
  • Lockheed Martin Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.19M in Q1 2017.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.